Immunic AG | Finanzwire

Basculer en Français

10793	Companies
233179	Keywords
161777	Articles
124386	Press releases

Home
Companies
Immunic AG

BRIEF

published on 05/13/2026 at 12:35, 2 months 20 days ago

Immunic, Inc. Reports Key Financial and Strategic Updates for Q1 2026

Immunic, Inc. Multiple Sclerosis Vidofludimus Calcium Q1 2026 Results Biotechnology Funding
PRESS RELEASE

published on 05/13/2026 at 12:30, 2 months 20 days ago

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. announces First Quarter 2026 Financial Results and corporate updates including appointment of Michael A. Panzara, M.D., M.P.H. as Chief Medical Officer and progress in ENSURE Trials for MS treatment

Financial Results Corporate Update Immunic Inc. First Quarter 2026 Michael A. Panzara
BRIEF

published on 04/30/2026 at 12:35, 3 months 2 days ago

Immunic to Attend Key Conferences in May

Vidofludimus Calcium Multiple Sclerosis Research Immunic Conferences Bio€quity Europe Biotechnology News
PRESS RELEASE

published on 04/30/2026 at 12:30, 3 months 2 days ago

Immunic to Participate in Investor and Medical Conferences in May
Immunic, Inc. (Nasdaq: IMUX) to participate in investor and medical conferences in May to present innovative therapies for neurologic diseases

Investor Conferences Immunic Medical Conferences Novel Therapies Neurologic Diseases
BRIEF

published on 04/28/2026 at 12:35, 3 months 4 days ago

Immunic Appoints Michael A. Panzara as Chief Medical Officer

Chief Medical Officer Immunic Inc. Vidofludimus Calcium Michael A. Panzara Neurology Drug Development
PRESS RELEASE

published on 04/28/2026 at 12:30, 3 months 4 days ago

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
Immunic appoints Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, bringing extensive experience in neurology drug development and regulatory approvals. Company transitions into a fully integrated commercial-stage entity

Chief Medical Officer Immunic Neurology Commercial-stage Michael A. Panzara
BRIEF

published on 04/23/2026 at 14:05, 3 months 9 days ago

Immunic, Inc. Announces 1-for-10 Reverse Stock Split

Reverse Stock Split Immunic Inc. Stockholder Meeting Share Reduction Nasdaq IMUX
PRESS RELEASE

published on 04/23/2026 at 14:00, 3 months 9 days ago

Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Immunic, Inc. announces a 1-for-10 reverse stock split to meet contractual obligations, reducing outstanding shares from 136M to 13.6M

Shareholders Reverse Stock Split Nasdaq Immunic Inc. Neurologic Diseases
BRIEF

published on 04/09/2026 at 12:35, 3 months 23 days ago

Immunic to Engage in Key Scientific Conferences in April

Biotechnology Clinical Trials Conférences Oral Therapies Neurology
PRESS RELEASE

published on 04/09/2026 at 12:30, 3 months 23 days ago

Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. to participate in scientific and medical conferences in April. Presentation on vidofludimus calcium for treating multiple sclerosis at the Neuroimmunology Drug Development Summit and AAN Annual Meeting

Immunic Inc. Multiple Sclerosis Vidofludimus Calcium Scientific Conferences Medical Conferences

Accesswire

Published on 08/01/2026 at 01:20, 1 day 16 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 16 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 17 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 17 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 1 day 18 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/02/2026 at 08:15, 9 hours 15 minutes ago

Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 21 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 22 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 1 day 22 hours ago

Holding(s) in Company

Les Echos

Published on 07/31/2026 at 21:00, 1 day 20 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 1 day 22 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 1 day 22 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 1 day 22 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 23 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE